Bank Hapoalim Raises Camtek's Target Price, Foresees $1.2 Billion Revenue by 2029

Camtek, a developer and manufacturer of inspection and measurement systems for the semiconductor industry, has set new targets for the coming years, with Bank Hapoalim revising its projections upward. Following a recent investor meeting, the bank increased its price target for Camtek shares by approximately 9% to $183, reflecting a potential upside of about 35% from the current share price. The bank maintained its "outperform" recommendation, classifying the investment as high-risk.

The primary driver for the revised outlook is not a minor improvement in the near-term forecast but an anticipated significant leap in activity in 2027. Camtek is benefiting from increased investments in advanced packaging and HBM (High Bandwidth Memory), crucial for AI accelerators. The company expects demand to drive revenue growth of over 35% next year, nearly doubling its current operational scale. Bank Hapoalim's analysis suggests that preliminary results and new forecasts strengthen the belief in accelerated growth for Camtek in the latter half of this year, with the most significant changes expected beyond 2026.

Camtek reported preliminary third-quarter revenues between $160-$161 million, a 27% year-over-year increase. For the fourth quarter, it anticipates revenues of approximately $180 million, a 41% year-over-year rise. Full-year 2026 revenues are projected to reach about $595 million, a 20% increase. However, the more substantial figure is the 2027 forecast, with Camtek estimating revenues exceeding $800 million, up from Bank Hapoalim's previous estimate of $738 million. Analyst Shi Zigelman raised his 2027 revenue forecast to $805 million and adjusted earnings per share to $5.21, projecting a 35% revenue and 45% EPS growth.

Looking further ahead, Camtek has presented a target of approximately $1.2 billion in organic revenue within three years, a significant increase from its previous target of $750 million. Bank Hapoalim estimates Camtek could reach $1 billion in revenue by 2028 and $1.2 billion by 2029. This growth is expected to stem from continued investment in chip manufacturing, the increasing complexity of chips requiring more testing, and the introduction of higher-priced, advanced systems like the Eagle G5 and Hawk. Additionally, Camtek aims to expand its services and software business, targeting around $140 million in revenue from this segment by 2027, a fivefold increase from 2025 levels.

Despite the revenue growth projections, Camtek has only slightly improved its adjusted gross profit margin target to 55%-56% and operating profit margin to 34%-36%. This is attributed to planned increases in R&D spending, with projected R&D expenses rising to $120 million under the $1.2 billion revenue target, compared to $58 million this year. Bank Hapoalim views this as a reasonable strategy to maintain Camtek's technological edge. The bank anticipates a notable improvement in operating profit margin from approximately 29.2% in 2026 to 33.5% in 2027.

The bank's price target increase is based on the revised earnings forecast, maintaining a price-to-earnings multiple of 32 for projected 2027 earnings. Camtek shares are currently trading at a multiple of about 26 times projected 2027 earnings. Bank Hapoalim considers the recent share price drop, coupled with improved forecasts, to enhance the risk-reward ratio. However, the bank reiterates the high-risk classification due to the semiconductor industry's cyclical nature, significant exposure to China (91% of revenues), and potential risks from export restrictions and US-China tensions. The upcoming third-quarter earnings report will be crucial for investors to assess profitability, R&D expenses, and cash flow, focusing on whether sales growth translates into improved profits as projected.